HRT does not increase breast cancer risk in BRCA1/BRCA2 variant carriers, with lower incidence in users versus non-users. Estrogen-alone therapy is linked to reduced mortality, while estrogen plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback